Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

Community colleges are playing an important role in training the workforce for economic development in the state, Chancellor ...

A historic office building that’s been vacant for six years in downtown Newark would be converted into 195 units of affordable housing by a prominent developer who says his success over 50 years made ...

President Donald Trump on Thursday named Medicare director and former health care executive Chris Klomp to be deputy ...

The Department of Justice Antitrust Division’s Whistleblower Rewards Program has attracted significant attention since its launch in 2025 ...

Pennsylvania Senator Dave McCormick visited Ephrata on Friday.

Industry-Recognized Certifications Help Building Materials Professionals Validate Skills, Advance Careers, and Maximize Technology Investments ...

Summer is the peak season for fun-in-the-sun adventures like traveling, camping, sports, cookouts, tailgates and other ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

Senator Boozman has proposed a draft version for a Farm Bill 2.0, bringing Congress one step closer to finally passing an ...

Women's Refugee Care serves families in RI from the moment they arrive. Lt. Gov. Sabina Matos shares her family's own ...

The Texas Supreme Court has temporarily blocked Harris officials from financially supporting nonprofits that assist ...